Thrombolysis in peripheral artery disease

Ther Adv Cardiovasc Dis. 2017 Apr;11(4):125-132. doi: 10.1177/1753944716687517. Epub 2017 Feb 5.

Abstract

Peripheral artery disease (PAD) has been associated with severe morbidity and mortality worldwide, affecting the quality of life for millions of patients. Acute thrombosis has been identified as a major complication of PAD, with proper management including both open as well as endovascular techniques. Thrombolysis has emerged as a reasonable option in the last decades to treat such patients although data produced by randomized trials have been limited. This review aims to present major aspects of thrombolysis in PAD regarding its indications and contraindications, technique tips as well as to review literature data in order to produce useful conclusions for everyday clinical practice.

Keywords: peripheral artery disease; review; thrombolysis.

Publication types

  • Review

MeSH terms

  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Patient Selection
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / drug therapy*
  • Peripheral Arterial Disease / physiopathology
  • Quality of Life
  • Risk Factors
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / methods*
  • Treatment Outcome
  • Vascular Patency / drug effects

Substances

  • Fibrinolytic Agents